High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
Glycan structures attached to the C(H)2 domain of the Fc region of immunoglobulin G (IgG) are essential for specific effector functions but their role in modulating clearance is less